Nebius Enters Its August 12 Reckoning With a Burry Short Hanging ...
Lenovo Shares Hit Fresh 52-Week Peak as Investors Pile In Ahead ...
Kioxia's Bipolar Market: Record Results a Looming Verdict and ...
Two Firms Convicted Over Fatal Fall of Window Pane at London ...
AXT's Indium Phosphide Surge: How One Semiconductor Supplier ...
Li-FT Power s C$20M Placement Puts a Clock on Québec s Regulatory ...
Western Digital's Margin Guidance Steals the Spotlight From a ...
D-Wave Quantum's Numbers Tell Two Stories — And the Market ...
SolarEdge s Recovery Has a Split Personality — and Wall Street Can ...
Fujikura s Earnings Explosion Reshapes the Investment Case for Japan ...
Aixtron's Two-Front Battle: A Record Order Pipeline Against a ...
Zurich Insurance's Record Profit Hides a Tangle of Regulatory ...
Commerzbank s Record Results Land as Frankfurt s Resistance to ...
SK Hynix's $38 Billion Expansion Puts Shareholder Returns in ...
Airbus's Summer of Contradictions: Record Orders Stuttering Deliveries ...
Siemens Energy's Rebound Has a Wrinkle: A Board Meeting a Rebrand ...
Palantir s Earnings Fireworks Mask a Deeper Question: Who s Selling ...
Nvidia's $500 Billion Bet: Can the AI Infrastructure Boom Survive ...
DEUTZ AG: Dr. Sebastian C. Schulte, buy
Guotai Haitong Proposes Privatisation of Guotai Junan International ...
Nel ASA Faces a Defining Stretch: Order Momentum Meets a Steep ...
AppLovin's Summer Slide: A Growth Premium Put to the Test
Zurich Insurance's Record Half-Year Masks a Web of Crosscurrents ...
SAP s Rally Has a Speed Problem: Strong Fundamentals, Overbought Charts, and a Street That Can ...
PANDION's Missed Coupon Puts a Restructured Bond Back Under the ...
Poste's €13.4bn Telecom Italia Bid Gathers Momentum as Operator ...
Powermax Minerals Runs the Clock on Cameron Field Season While ...
PANDION s Missed Coupon: A Test of Whether the Developer s Woes ...
Atlassian Shares Surge Past €120 as Cloud Momentum Silences ...
Li-FT Power s October Deadline: A C$20 Million Bet on Québec ...
PANDION's Missed Coupon Leaves Bondholders Counting Down to a ...
Replimune's Conditional Comeback: FDA Approval Ends a Bruising ...